Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

APEX 6

K-Number: K220122 · 2023-03-15

Decision Date2023-03-15
Product CodeGXD
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

APEX 6 is a medical device manufactured by Rf Innovations, Inc.. It received FDA 510(k) clearance on 2023-03-15 under approval number K220122. The device is classified under product code GXD. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the APEX 6?

APEX 6 is a medical device that received FDA 510(k) clearance on 2023-03-15. It is manufactured by Rf Innovations, Inc.. The 510(k) number is K220122.

When was APEX 6 approved by the FDA?

APEX 6 received FDA 510(k) clearance on 2023-03-15, under approval number K220122.

What company makes APEX 6?

APEX 6 is manufactured by Rf Innovations, Inc..

What is the FDA product code for APEX 6?

The FDA product code for APEX 6 is GXD.

Related Devices (Code: GXD)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.